These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16563041)

  • 21. Direct-to-consumer advertising under the radar: the need for realistic drugs policy in Australia.
    Mackenzie FJ; Jordens CF; Ankeny RA; McPhee J; Kerridge IH
    Intern Med J; 2007 Apr; 37(4):224-8. PubMed ID: 17388861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ban the sunset? Nonpropositional content and regulation of pharmaceutical advertising.
    Biegler P; Vargas P
    Am J Bioeth; 2013; 13(5):3-13. PubMed ID: 23557035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost-effectiveness of direct-to-consumer advertising for prescription drugs.
    Atherly A; Rubin PH
    Med Care Res Rev; 2009 Dec; 66(6):639-57. PubMed ID: 19423875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The opinions and experiences of family physicians regarding direct-to-consumer advertising.
    Lipsky MS; Taylor CA
    J Fam Pract; 1997 Dec; 45(6):495-9. PubMed ID: 9420585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct-to-consumer-advertising of prescription medicines: a theoretical approach to understanding.
    Harker M; Harker D
    Leadersh Health Serv (Bradf Engl); 2007; 20(2):76-84. PubMed ID: 20690467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites.
    Tyrawski J; DeAndrea DC
    J Med Internet Res; 2015 Jun; 17(6):e130. PubMed ID: 26032738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of oncology-related direct-to-consumer advertising: association with appropriate and inappropriate prescriptions.
    Abel GA; Chen K; Taback N; Hassett MJ; Schrag D; Weeks JC
    Cancer; 2013 Mar; 119(5):1065-72. PubMed ID: 23132702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand. 'Possums in the headlights?'.
    Toop L; Richards D; Dowell T
    Br J Gen Pract; 2003 Apr; 53(489):342-5. PubMed ID: 12879848
    [No Abstract]   [Full Text] [Related]  

  • 29. The impact of direct-to-consumer advertised drugs on drug sales in the US and New Zealand.
    Norey E; Simone TM; Mousa SA
    Appl Health Econ Health Policy; 2008; 6(2-3):93-102. PubMed ID: 19231903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintaining a Fair Balance? Narrative and Non-Narrative Strategies in Televised Direct-to-Consumer Advertisements for Prescription Drugs Aired in the United States, 2003-2016.
    Liu J; Avery RJ; Kim JJ; Niederdeppe J
    J Health Commun; 2022 Mar; 27(3):183-191. PubMed ID: 35593131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit?
    Toop L; Richards D; Saunders B
    N Z Med J; 2003 Aug; 116(1180):U556; discussion U556. PubMed ID: 14581976
    [No Abstract]   [Full Text] [Related]  

  • 32. Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements.
    Hall DV; Jones SC
    Aust N Z J Public Health; 2008 Oct; 32(5):471-8. PubMed ID: 18959553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of direct-to-consumer drug advertising during the Super Bowl on drug utilization.
    Gray MP; San-Juan-Rodriguez A; Chen N; Good CB; Hernandez I
    Res Social Adm Pharm; 2020 Aug; 16(8):1136-1139. PubMed ID: 31864886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct-to-physician and direct-to-consumer advertising: Time to have stringent regulations.
    Kannan S; Gowri S; Tyagi V; Kohli S; Jain R; Kapil P; Bhardwaj A
    Int J Risk Saf Med; 2015; 27(2):77-83. PubMed ID: 26410010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct-to-consumer advertising: public perceptions of its effects on health behaviors, health care, and the doctor-patient relationship.
    Murray E; Lo B; Pollack L; Donelan K; Lee K
    J Am Board Fam Pract; 2004; 17(1):6-18. PubMed ID: 15014047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The politics and strategy of industry self-regulation: the pharmaceutical industry's principles for ethical direct-to-consumer advertising as a deceptive blocking strategy.
    Arnold DG; Oakley JL
    J Health Polit Policy Law; 2013 Jun; 38(3):505-44. PubMed ID: 23418365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct-to-Consumer Drug Advertisement and Prescribing Practices: Evidence Review and Practical Guidance for Clinicians.
    Franquiz MJ; McGuire AL
    J Gen Intern Med; 2021 May; 36(5):1390-1394. PubMed ID: 32930939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct-to-consumer television advertising exposure, diagnosis with high cholesterol, and statin use.
    Niederdeppe J; Byrne S; Avery RJ; Cantor J
    J Gen Intern Med; 2013 Jul; 28(7):886-93. PubMed ID: 23463454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The legal and ethical dimensions of direct-to-consumer advertising of prescription drugs: the case of Pfizer and Lipitor in the United States.
    Koku PS
    Health Mark Q; 2021; 38(1):23-34. PubMed ID: 34219606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in direct-to-consumer advertising of prescription contraceptives.
    Wu MH; Bartz D; Avorn J; Seeger JD
    Contraception; 2016 May; 93(5):398-405. PubMed ID: 26808088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.